Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.
about
SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor functionAnalysis of gene expression data from non-small cell lung carcinoma cell lines reveals distinct sub-classes from those identified at the phenotype levelGastrokines: stomach-specific proteins with putative homeostatic and tumor suppressor roles.Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Trefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-upMultiple endocrine neoplasia type 1 associated with breast cancer: A case report and review of the literatureSerum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancerTFF1 activates p53 through down-regulation of miR-504 in gastric cancerExploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements.Activation of β-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis.Functional expression of recombinant human trefoil factor 1 by Escherichia coli and Brevibacillus choshinensisExploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.An integrative and comparative study of pan-cancer transcriptomes reveals distinct cancer common and specific signatures.SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis.Histone H3 phosphorylation, immediate-early gene expression, and the nucleosomal response: a historical perspective.Genetics of breast cancer bone metastasis: a sequential multistep pattern.Trefoil factor family peptides--friends or foes?IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines.Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays.Loss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of RORγt+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia.High trefoil factor 1 (TFF1) expression in human retinoblastoma cells correlates with low growth kinetics, increased cyclin-dependent kinase (CDK) inhibitor levels and a selective down-regulation of CDK6.TFF1 hypermethylation and decreased expression in esophageal squamous cell carcinoma and histologically normal tumor surrounding esophageal cells.Increased immunoexpression of trefoil factors in salivary gland tumors.Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers.TFF1 and TFF3 mRNAs Are Higher in Blood from Breast Cancer Patients with Metastatic Disease than Those without.
P2860
Q24339302-8DDD7D0F-1D80-4F87-80B6-3EE552217D48Q28485331-B6D64FAA-CB3D-4426-BE4F-6B3A17B870CCQ30577615-4A25EF6D-D19D-492E-A209-006DA14BAAB3Q31111254-53169A5E-D17C-481F-B1BA-AF75D72D9714Q33628415-2E5CB19C-44DE-4BC2-AA2A-4F7D520C572FQ33778307-F389D85A-27FE-4608-B409-E19BA6A6A6B1Q33885064-325F398A-B0D5-43ED-AD31-BF9AC817C0A8Q33970563-8709BA83-2459-4C22-8512-8DB827BD3EF4Q34221596-C7C74A63-DCAF-4A99-A506-5EA26E13CE10Q34579904-7D51C48D-C937-449F-B6D4-1C9ED12AF4FDQ35000343-D5F685E7-FFEA-4722-9A25-392287E16E75Q35061777-223AACEB-818D-4CC8-910D-A439C2A83F2CQ35626694-76EE14C4-AD16-4B5F-AE4C-DB2FC88B2B19Q35824890-41BCE9FF-185F-4FEB-870B-94DC6AFDF8A4Q36228457-A38C46DA-0D37-4605-82D7-1E722C8A99A7Q36642525-E3542A37-DA36-4C21-A595-750CCB283E33Q37260793-119658A6-BFE0-45EF-B07B-70982A1FE5DAQ37417663-93DC5BC5-2754-4074-AE18-B39C4B1E7FEBQ37976424-20FB774F-273C-4BF1-9D02-4BF0DB8F5287Q38184928-ABA4A0B4-4A60-4E29-B96B-D42500AB97D4Q38610757-8E37287C-10F7-4EBC-A310-AAF29A645F8EQ38707271-4E4E8C11-FE02-4BC7-B26F-0890612CB011Q38798656-7AD16930-6A5B-470A-BF62-0AF25BA6274DQ39055609-51DA07B2-A126-4B16-9C66-6EAAF5CA88D4Q40090503-A017D639-2432-4846-9C5C-9398D757012AQ41243646-3D402A55-7CDC-418E-A521-7E24317F533EQ46060547-C4644123-0C2B-4CCB-AEEE-A3B81E1F2D05Q47140299-85EDB895-70D6-4121-A65E-AB382D5F5F50Q47743907-7F77EA82-88F4-4F00-AEEA-8D9B9A3113A5Q48189942-29F84CA4-55F9-4774-8D0C-85C47CC365D0Q55413875-0E2F5565-DE9E-43AB-844B-41D3A399EAE6
P2860
Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Deficiency in trefoil factor 1 ...... lopment in TFF1-knockout mice.
@ast
Deficiency in trefoil factor 1 ...... lopment in TFF1-knockout mice.
@en
type
label
Deficiency in trefoil factor 1 ...... lopment in TFF1-knockout mice.
@ast
Deficiency in trefoil factor 1 ...... lopment in TFF1-knockout mice.
@en
prefLabel
Deficiency in trefoil factor 1 ...... lopment in TFF1-knockout mice.
@ast
Deficiency in trefoil factor 1 ...... lopment in TFF1-knockout mice.
@en
P2093
P2860
P50
P356
P1433
P1476
Deficiency in trefoil factor 1 ...... elopment in TFF1-knockout mice
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.41
P407
P577
2011-02-28T00:00:00Z